All In Biotech

Drug Trial Radar · NCT00969709

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Oct 25, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 724 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

724

Actual

Start

Sep 2009

Primary completion

May 2011

Sponsor

Lead sponsor
Forest LaboratoriesAbbVie (ABBV)
Sponsor type
Industry
First posted
Sep 1, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.

Conditions

  • Major Depressive Disorder

Interventions

  • Levomilnacipran ERDrug

    Levomilnacipran ER, 40 mg, oral administration, in capsule form, once daily for 8 weeks.

  • Levomilnacipran ERDrug

    Levomilnacipran ER, 80 mg, oral administration, in capsule form, once daily for 8 weeks.

  • Levomilnacipran ERDrug

    Levomilnacipran ER, 120 mg, oral administration, in capsule form, once daily for 8 weeks.

  • PlaceboDrug

    Matching placebo capsules, oral administration, once daily for 8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Total ScoreTime frame: From Baseline to Week 8

Locations

38 sites in 1 country. Site status is shown where the registry gives one.

  • Forest Investigative Site

    Phoenix, Arizona

  • Forest Investigative Site

    Scottsdale, Arizona

  • Forest Investigative Site

    Beverly Hills, California

  • Forest Investigative Site

    Costa Mesa, California

  • Forest Investigative Site

    Escondido, California

  • Forest Investigative Site

    Oceanside, California

  • Forest Investigative Site

    Sherman Oaks, California

  • Forest Investigative Site

    Denver, Colorado

  • Forest Investigative Site

    Cromwell, Connecticut

  • Forest Investigative Site

    Coral Springs, Florida

  • Forest Investigative Site

    Fort Myers, Florida

  • Forest Investigative Site

    Hallandale, Florida

  • Forest Investigative Site

    Jacksonville, Florida

  • Forest Investigative Site

    Orlando, Florida

  • Forest Investigative Site

    West Palm Beach, Florida

  • Forest Investigative Site

    Hoffman Estates, Illinois

  • Forest Investigative Site

    Wichita, Kansas

  • Forest Investigative Site

    Baltimore, Maryland

  • Forest Investigative Site

    Rockville, Maryland

  • Forest Investigative Site

    Cherry Hill, New Jersey

  • Forest Investigative Site

    Willingboro, New Jersey

  • Forest Investigative Site

    Brooklyn, New York

  • Forest Investigative Site

    Mount Kisco, New York

  • Forest Investigative Site

    New York, New York

  • Forest Investigative Site

    New York, New York

  • Forest Investigative Site

    Staten Island, New York

  • Forest Investigative Site

    Raleigh, North Carolina

  • Forest Investigative Site

    Canton, Ohio

  • Forest Investigative Site

    Portland, Oregon

  • Forest Investigative Site

    Media, Pennsylvania

  • Forest Investigative Site

    Norristown, Pennsylvania

  • Forest Investigative Site

    Lincoln, Rhode Island

  • Forest Investigative Site

    Memphis, Tennessee

  • Forest Investigative Site

    Dallas, Texas

  • Forest Investigative Site

    Dallas, Texas

  • Forest Investigative Site

    San Antonio, Texas

  • Forest Investigative Site

    Bellevue, Washington

  • Forest Investigative Site

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.